When it comes to breakthrough therapies, sometimes it seems as though each new potentially life-saving drug comes with a price tag more expensive than the last. Novartis’ Kymriah, which became the first to win FDA approval for a groundbreaking new type of cancer treatment called CAR-T last year, priced its therapy at…
Source: Gizmodo – How Much Is Too Much For a Life-Saving Drug?